Latest Leadership News

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Guzman y Gomez Limited (GYG) reported a strong FY25 turnaround with revenue up 27% and a maiden fully franked dividend declared, underpinned by robust Australia segment growth and ongoing US expansion.

Altamin Limited announces a significant board and executive reshuffle, appointing Peter Edwards as non-executive Chairman and Geraint Harris as incoming CEO, signaling a renewed focus on critical raw materials for Europe’s energy transition.

Credit Clear Limited has reported a remarkable turnaround in FY25, posting record revenue growth and a return to profitability driven by its innovative AI-powered debt resolution platform.

BSP Financial Group Limited has reported a robust half-year performance for 1H25, marked by nearly 10% growth in revenue and net profit after tax, alongside a healthy capital position and an increased interim dividend.

BSP Financial Group reported a solid 9.8% increase in net profit after tax for the first half of 2025, driven by strong revenue growth and strategic investments in digital banking. The bank also raised its interim dividend by 11.1%, reflecting confidence in its ongoing modernization efforts.

AMA Group Limited reported a robust FY25 with revenue climbing 8.6% to over $1 billion and a 38.4% jump in normalised EBITDA, while significantly reducing net debt following a major equity raise and debt refinancing.

LaserBond announces a strategic leadership transition with Rob Freeman appointed CEO, succeeding long-time leader Wayne Hooper who remains as Executive Director in an advisory capacity.

Cogstate Ltd has reported a strong FY25 with 22% revenue growth and a near doubling of profit before tax, declaring its first fully franked dividend and preparing to launch its inaugural AI-powered product in FY26.

Cogstate Limited has reported a landmark FY25 with revenue up 22% and net profit before tax nearly doubling, driven by a surge in clinical trials contracts and strategic innovation. The company also declared its maiden fully franked dividend and outlined ambitious growth plans including AI product launches and an expanding Medidata partnership.

GQG Partners Inc. reported robust first-half 2025 results with revenue up 11% and net income rising 14.4%, alongside a new US ETF launch and a declared interim dividend.

Cuscal Limited reported a 6% revenue increase for FY25 and announced a strategic acquisition of Indue, alongside a leadership change and a higher final dividend.